Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s boarders.

Episode 89: Cellicon Valley Outlook

Chris DiCostanzo, VP of patient engagement solutions for OptimizeRx, a provider of digital health tools and strategies to improve drug affordability and adherence, discusses the challenges encountered most today in therapy initiation and maintaining treatment—and how new approaches in brand communication and messaging, including the use of AI-driven real-world evidence, can deliver benefits to patients, physicians and manufacturers at the point-of-care.

The Pursuit of Precision in Point-of-Care Support

Pharmaceutical Commerce Magazine

Related tracks